No Data
No Data
No Data
No Data
No Data
What Royalty Pharma Plc's (NASDAQ:RPRX) P/S Is Not Telling You
You may think that with a price-to-sales (or "P/S") ratio of 5.3x Royalty Pharma plc (NASDAQ:RPRX) is a stock to avoid completely, seeing as almost half of all the Pharmaceuticals companies in the Uni
Simply Wall StApr 25 21:40
Press Release: PureTech Announces Annual Results -36-
For the years ended December 31, 2023 and 2022, the Group recognized the following changes in the value of subsidiary preferred shares:
Dow JonesApr 25 17:35
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21
Yahoo FinanceApr 20 20:29
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 before the U.S. financial markets
GlobeNewswireApr 19 20:15
Royalty Pharma To Go Ex-Dividend On May 16th, 2024 With 0.21 USD Dividend Per Share
April 18th - $Royalty Pharma(RPRX.US)$ is trading ex-dividend on May 16th, 2024. Shareholders of record on May 17th, 2024 will receive 0.21 USD dividend per share on June 14th, 2024. The ex-divide
Futu NewsApr 18 07:40
Royalty Pharma Maintains Quarterly Dividend at $0.21 per Share, Payable June 14 to Shareholders of Record May 17
03:06 PM EDT, 04/17/2024 (MT Newswires) -- Royalty Pharma Maintains Quarterly Dividend at $0.21 per Share, Payable June 14 to Shareholders of Record May 17
MT NewswiresApr 18 03:06
No Data
No Data